Abiopharma

🔍 PERCEPTIVE ADVISORS LLC (Executive)

Company: MeiraGTx Holdings plc (MGTX)

Report Date: 2022-08-02

Detailed Transactions and Holdings:

• Acquired 555,555 shares of Ordinary Shares at $9.0 per share (Direct)
  Date: 2026-04-17 | Code: A | equity_swap_involved: false | shares_owned_after: 10,786,658.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 400,000 shares of Warrant (Right to Buy) at $15.0 per share (Derivative)
  Date: 2022-08-02 | Code: A | Expires: 2027-08-02 | Exercise: 2022-08-02 | equity_swap_involved: false | shares_owned_after: 400,000.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 300,000 shares of Warrant (Right to Buy) at $20.0 per share (Derivative)
  Date: 2022-08-02 | Code: A | Expires: 2027-08-02 | Exercise: 2022-08-02 | equity_swap_involved: false | shares_owned_after: 300,000.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Sold 400,000 shares of Warrant (Right to Buy) at $15.0 per share (Derivative)
  Date: 2026-03-25 | Code: D | Expires: 2027-08-02 | Exercise: 2022-08-02 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 300,000 shares of Warrant (Right to Buy) at $20.0 per share (Derivative)
  Date: 2026-03-25 | Code: D | Expires: 2027-08-02 | Exercise: 2022-08-02 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F2
• Acquired 400,000 shares of Warrant (Right to Buy) at $8.0 per share (Derivative)
  Date: 2026-03-25 | Code: A | Expires: 2027-08-02 | Exercise: 2026-03-25 | equity_swap_involved: false | shares_owned_after: 400,000.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Acquired 300,000 shares of Warrant (Right to Buy) at $8.0 per share (Derivative)
  Date: 2026-03-25 | Code: A | Expires: 2027-08-02 | Exercise: 2026-03-25 | equity_swap_involved: false | shares_owned_after: 300,000.00 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
• F2: Issued to Perceptive Credit Holdings III, LP ("Credit Fund III") in connection with the senior secured financing arrangement (the "Financing Agreement") by and among the Issuer, PCH III, and the other parties thereto. Perceptive Credit Advisors LLC ("Perceptive Credit Advisors") serves as the investment advisor to Credit Fund III and as a relying advisor under the Advisor. Mr. Edelman is the managing member of Perceptive Credit Advisors. Each of Perceptive Credit Advisors, the Advisor and Mr. Edelman disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that any of Perceptive Credit Advisors, the Advisor and Mr. Edelman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
• F3: On March 25, 2026, the Issuer, Credit Fund III, and the other parties to the Financing Agreement entered into an agreement whereby the exercise price of the warrants was adjusted to $8.00 per share.
• REMARKS: Ellen Hukkelhoven, the Head of Investment Research of the Advisor, is a member of the Issuer's board of directors.